3 New Integrated HPLC System Significantly Improves Analytical Productivity
Shimadzu has released the new i-Series Plus integrated HPLC. This compact solution covers conventional to ultra-fast LC analysis. Application-specific solutions are available within the product range such as the Cannabis Analyzer for potency testing of primary active components of cannabis for medical use. It offers a simple procedure, complete with a column, methods, batches and report templates.
With the i-Series Plus, pretreatment operations have been automated, such as the processes to dilute samples and add reagents. This results in less mistakes and measurement errors and ensures highly reproducible and reliable data in the analysis of pharmaceuticals and foods. i-Series Plus also offers compliance features satisfying the data integrity requirements of the pharmaceutical industry.
Since the release of i-Series systems in 2014, 10,000 units have been sold around the world. i-Series systems have been used for research and development activities, specification tests and quality control operations in a wide range of application fields, such as pharmaceutical, chemical and food industries.
i-Series Plus expands the product line and improves performance and user-friendliness. The character ‘I’ in i-Series stands for ‘innovative’ for further advancement, ‘intuitive’ for user-friendly features and ‘intelligent’ for the system’s self-diagnostic tools. The new system is equipped with a function to automate sample pretreatment, which serves to minimise operator mistakes and measurement errors, improve separation of the target components and to enhance sensitivity. Core features are:
The i-Series Plus consists of the compact HPLC Prominence-i and UHPLC system Nexera-i. High speed analysis, simplified method transfer, minimised environmental impact and easy maintenance are just a few of the many new features of this product range.
For more information visit
www.shimadzu.com
DryLab®4. Exceptionally Efficient Software for U(H)PLCModeling
up to
Method Runtime and
up to
Development Time
97% 92%
Saves
www.molnar-institute.com
DryLab reduces HPLC runtime up to 40-foldwhile delivering improved selectivity.[1]
[1] Schmidt,Molnár / J. Pharm. Biomed. Anal. 78–79 (2013) 65–74
With DryLab, the time needed for HPLC method development is reduced up to 12-fold.[2]
[2] Kochling et al. / J. Pharm. Biomed. Anal. 125 (2016) 130–139
A1/#228
analytica Booth
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68
